DE3868051D1 - Potenzierung der antihypertensiven wirkung von ace-inhibitoren. - Google Patents

Potenzierung der antihypertensiven wirkung von ace-inhibitoren.

Info

Publication number
DE3868051D1
DE3868051D1 DE8888909317T DE3868051T DE3868051D1 DE 3868051 D1 DE3868051 D1 DE 3868051D1 DE 8888909317 T DE8888909317 T DE 8888909317T DE 3868051 T DE3868051 T DE 3868051T DE 3868051 D1 DE3868051 D1 DE 3868051D1
Authority
DE
Germany
Prior art keywords
potentializing
ace inhibitors
hypertensive effect
hypertensive
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888909317T
Other languages
English (en)
Inventor
M Ksander
B Zimmerman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of DE3868051D1 publication Critical patent/DE3868051D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8888909317T 1987-10-19 1988-10-11 Potenzierung der antihypertensiven wirkung von ace-inhibitoren. Expired - Lifetime DE3868051D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/109,965 US4962105A (en) 1987-10-19 1987-10-19 Potentiation of antihypertensive effect of ace inhibitors
PCT/EP1988/000909 WO1989003691A1 (en) 1987-10-19 1988-10-11 Potentiation of antihypertensive effect of ace inhibitors

Publications (1)

Publication Number Publication Date
DE3868051D1 true DE3868051D1 (de) 1992-03-05

Family

ID=22330532

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888909317T Expired - Lifetime DE3868051D1 (de) 1987-10-19 1988-10-11 Potenzierung der antihypertensiven wirkung von ace-inhibitoren.

Country Status (11)

Country Link
US (1) US4962105A (de)
EP (1) EP0336950B1 (de)
JP (1) JPH02501655A (de)
KR (1) KR890701136A (de)
AU (1) AU617385B2 (de)
DE (1) DE3868051D1 (de)
DK (1) DK299489A (de)
IL (1) IL88037A0 (de)
NZ (1) NZ226589A (de)
WO (1) WO1989003691A1 (de)
ZA (1) ZA887764B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5073539A (en) * 1990-01-22 1991-12-17 Ciba-Geigy Corporation Transdermal administration of zwitterionic drugs
US5821232A (en) * 1990-05-11 1998-10-13 Pfizer Inc. Synergistic therapeutic compositions and methods
DK0527879T3 (da) 1990-05-11 1997-07-14 Pfizer Synergistiske terapeutiske præparater og fremgangsmåder.
AR072297A1 (es) 2008-06-27 2010-08-18 Novartis Ag Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4478842A (en) * 1981-11-19 1984-10-23 Ciba-Geigy Corporation N-Substituted-2-pyridylindoles
US4473575A (en) * 1982-07-19 1984-09-25 Ciba-Geigy Corporation 3-Amino-(1)-benzazepin-2-one-1-alkanoic acids
US4575503A (en) * 1983-02-10 1986-03-11 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
US4511573A (en) * 1983-05-17 1985-04-16 Ciba-Geigy Corporation 3-Substituted-2-(heteroaryl) indoles
DE3324263A1 (de) * 1983-07-06 1985-01-17 Hoechst Ag, 6230 Frankfurt Derivate der 2-azabicyclo(3.1.0)hexan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie 2-azabicyclo(3.1.0)hexan-derivate als zwischenprodukte und verfahren zu deren herstellung
US4600534A (en) * 1984-02-06 1986-07-15 Ciba-Geigy Corporation Process and intermediates for manufacture of 3-(5-amino-1-carboxypentylamino)-tetrahydro-1-benzazepin-2-one-1-acetic acid
US4666901A (en) * 1984-05-17 1987-05-19 Merck & Co., Inc. Substituted lactams useful as angiotensin converting enzyme inhibitors
DE3536687A1 (de) * 1985-10-15 1987-04-16 Hoechst Ag Verfahren zur behandlung von atherosklerose, thrombose und der peripheren gefaesskrankheit

Also Published As

Publication number Publication date
AU617385B2 (en) 1991-11-28
JPH02501655A (ja) 1990-06-07
EP0336950B1 (de) 1992-01-22
AU2608588A (en) 1989-05-23
NZ226589A (en) 1991-06-25
DK299489D0 (da) 1989-06-16
ZA887764B (en) 1989-06-28
US4962105A (en) 1990-10-09
EP0336950A1 (de) 1989-10-18
WO1989003691A1 (en) 1989-05-05
IL88037A0 (en) 1989-06-30
DK299489A (da) 1989-06-16
KR890701136A (ko) 1989-12-19

Similar Documents

Publication Publication Date Title
DE3879806D1 (de) Polymerisierung von aethylen.
ATE97652T1 (de) Peptidasehemmungsmittel.
DK674387D0 (da) Proteaseinhibitorer
DE3670633D1 (de) Stickstoffhaltige heterocyclische ester.
DE59006330D1 (de) Verteiler von Einzelstücken.
DE3574638D1 (de) Pruefung der echtheit von schriftzeichen.
DE68924670D1 (de) Alpha-glukosidase-Inhibitoren.
DK317287D0 (da) Reduktase-inhibitorer
NO883428L (no) N-substituerte benzamider.
DE3869007D1 (de) Oxydation von alkanen.
DE58901663D1 (de) I.m. injektionsformen von gyrase-inhibitoren.
FI865196A0 (fi) Halostatinsubstituerade renin-inhibitorer.
ATE112172T1 (de) Targetformer von antitumor-methyltrithioagenzien.
DK633289A (da) Retrovirale proteasehaemmere
DK588888D0 (da) Skibsbelaegninger der modvirker begroning
FI881972A0 (fi) Anvaendning av en ace-inhibitor foer inhibitering av foerlusten av kognitiva funktioner.
DE3868051D1 (de) Potenzierung der antihypertensiven wirkung von ace-inhibitoren.
ATE125794T1 (de) Prodrogen von antiinflammatorischen 3-acyl-2- oxindol-1-carboxamiden.
DK174087D0 (da) Angiotensinkonverterende enzyminhibitor
FI880291A (fi) Varpvaevd enkeltrikao med lugg.
DE3861556D1 (de) Verhinderung von ablagerungen.
DE3869828D1 (de) Stabilisierung von aminalane.
DE69002136D1 (de) Saccharidderivate von protocatechualdehyd.
DK69489A (da) Aspartattranscarbamylase-inhibitorer
ATE71844T1 (de) Potenzierung der antihypertensiven wirkung von ace-inhibitoren.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee